Sterilin’s single-use products are leveraged in sample collection, preservation, and processing. It offers a line of tissue culture plastics that complement Thermo Fisher’s line of plastic consumables. Headquartered in South Wales, U.K., Sterilin has approximately 270 employees. The business will be integrated into Thermo Fisher’s Laboratory Products and Services Segment.

“This acquisition broadens the range of innovative specialty laboratory products we can offer our customers,” says Marc N. Casper, president and CEO of Thermo Fisher Scientific. “It is also consistent with our strategy to leverage our global sales and support organization to give our customers across Europe, Asia-Pacific, and North America greater access to these products.”

Thermo Fisher Scientific’s last acquisition was in December 2010; it paid $2.1 billion for Dionex, which offers ion and liquid chromatography systems and consumables. The deal also expanded Thermo Fisher’s footprint in Asia Pacific and the environmental analysis market.

 

To read more click here